ACH (Accendra Health, Inc.) Stock Financials & Earnings

ACHAccendra Health, Inc.

Mkt Cap$185M

Revenue (TTM)$4.7B

Net Income (TTM)-$1.1B

EPS (TTM)-$14.29

Free Cash Flow (TTM)-$305M

Gross Margin31.0%

Op. Margin0.2%

Net Margin-23.3%

FCF Margin-6.5%

P/S Ratio (TTM)0.0x

P/E Ratio (TTM)—

YoY Rev Growth-29.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$2.5B	$497M	$10M
Q2 23	$2.6B	$519M	$11M
Q3 23	$2.6B	$538M	$24M
Q4 23	$2.7B	$570M	$60M
Q1 24	$2.6B	$536M	$10M
Q2 24	$660M	$316M	$17M
Q3 24	$687M	$332M	$31M
Q4 24	$2.7B	$580M	-$262M
Q1 25	$2.6B	$526M	$124K
Q2 25	$682M	$325M	-$40M
Q3 25	$697M	$322M	$26M
Q4 25	$709M	$290M	$22M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	—	—	$449M	—
Q2 23	—	—	$455M	—
Q3 23	—	—	$453M	—
Q4 23	$13M	$1.8B	—	—
Q1 24	—	—	$478M	—
Q2 24	—	—	$469M	—
Q3 24	—	—	$470M	—
Q4 24	—	$101M	—	—
Q1 25	—	—	$462M	—
Q2 25	—	—	—	$268M
Q3 25	—	—	—	$266M
Q4 25	—	—	—	$269M

Revenue Segments

Quarter	Patient Direct	Products & Healthcare Services	Diabetes Product	Product and Service, Other	Urology	Wound Care
Q1 23	$607M	$1.9B	—	—	—	—
Q2 23	$633M	$1.9B	—	—	—	—
Q1 24	$638M	$2.0B	—	—	—	—
Q4 24	$695M	$2.0B	—	—	—	—
Q1 25	$674M	$2.0B	—	—	—	—
Q4 25	—	—	$391M	$143M	$58M	$94M

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$67M	$0	$67M
Q2 23	$286M	$0	$286M
Q3 23	$215M	$0	$215M
Q4 23	$243M	$0	$243M
Q1 24	$245M	$0	$245M
Q2 24	$257M	$0	$257M
Q3 24	$45M	$0	$45M
Q4 24	$49M	$0	$49M
Q1 25	$59M	$0	$59M
Q2 25	$38M	$0	$38M
Q3 25	$33M	$0	$33M
Q4 25	$282M	$0	$282M

Shares Outstanding

Revenue Per Employee

Revenue / Employee